Initial briefing and material review
Review of the complaint, all materials under complaint, and relevant internal records. Initial assessment of the strength of the complaint and the likely PMCPA response approach.
Strategic Advisory Services
PMCPA complaints, product launches, inspection preparation, novel activity structures, board-level briefings. Compliance advice that tells you not just whether something is permissible — but how to structure it so it works commercially as well as legally.
Request a Consultation →The problem
Standard compliance guidance tells you what the rules say. Strategic advisory tells you how to navigate a specific situation — factoring in the commercial objective, the regulatory context, precedent from PMCPA case outcomes, and the risk profile of the specific structure being considered.
The way a company responds to a PMCPA complaint — the speed, tone, framing, and completeness of the response — materially affects the outcome. An uncoordinated response that volunteers additional information or mischaracterises the activity under complaint can convert a manageable situation into a formal breach finding.
Novel promotional approaches — interactive digital tools, patient-directed content, combined HCP and patient campaigns, social media strategies — create compliance questions that internal teams have never had to answer before. The pressure of a launch timeline does not leave room for iterative learning.
Patient organisation interactions, disease awareness campaigns, and patient support programmes each carry specific Code obligations that are distinct from standard HCP promotional activity. Board-level stakeholders need clear, confident advice — not a list of rules to read.
Digital channels move fast and compliance scrutiny often follows behind. Campaigns that are well-intentioned can carry structural issues — signposting failures, missing fair balance, promotional/non-promotional boundary breaches — that are not visible until an independent expert reviews the full structure.
Inspections reward documented processes, clear governance, and the ability to demonstrate compliant decision-making retrospectively. A gap analysis and mock audit before the real thing allows time to address weaknesses rather than explain them.
Many UK affiliates operate without a dedicated in-house compliance officer at the level required to advise on genuinely complex questions. External strategic advisory provides that expertise on a flexible basis — without the cost of a permanent hire.
Advisory areas
Strategic advisory engagements are structured around the specific situation. The six areas below cover the most common advisory contexts — all are available as retained, project-based, or ad hoc engagements.
From initial receipt through to written response submission. Material review, response strategy, case framing, and ongoing PMCPA liaison. Also available for pre-emptive complaint risk assessment where a complaint is anticipated.
Structural review of the planned promotional approach before any material enters the review cycle. Identifies Code exposure in campaign architecture, channel selection, and activity classification — before the cost of rework is at its highest.
Pre-inspection gap analysis, mock audit against ABPI and MHRA expectations, and a prioritised written report of findings. Ensures the organisation can demonstrate compliant decision-making with appropriate documentation before the inspection date.
Patient organisation interactions, disease awareness programmes, NIS studies, named patient schemes, and cross-border campaigns — each with specific Code obligations. Strategic advice on how to structure the activity to achieve the commercial objective within compliant boundaries.
Independent review of the structure, content, and channel strategy for digital campaigns, including social media, paid search, influencer-adjacent content, and interactive digital tools. Focus on structural Code compliance — not just claims review.
Ongoing senior compliance counsel on a retained basis — available for queries, reviews, and escalations as they arise. Provides continuity of expertise for organisations that need reliable compliance advice without the cost structure of a senior in-house hire.
How it works
PMCPA complaint management follows a defined process. The way each stage is handled determines the outcome. Speed, accuracy, and strategic framing of the response are all within your control — with the right advice from the outset.
Review of the complaint, all materials under complaint, and relevant internal records. Initial assessment of the strength of the complaint and the likely PMCPA response approach.
Framing of the company's response — what to address directly, what context to provide, and what to avoid volunteering. Strategy aligned with PMCPA procedural requirements and precedent from comparable case outcomes.
Drafting and review of the formal written response to the PMCPA. Every response is reviewed for completeness, tone, and strategic framing before submission.
Support through subsequent PMCPA correspondence, panel hearings where required, and any undertaking or remedial action process. Available for the full duration of the case.
Following complaint resolution, a review of current materials and activities for similar issues — preventing a resolved complaint from generating a second one from a different complainant.
Other strategic advisory contexts
How to structure named patient and early access activities without creating promotional material or crossing the boundary into unlicensed promotion.
Funding, collaboration, and joint working — ensuring patient organisation relationships meet the specific Code requirements for transparency, independence, and documentation.
Design and conduct of NIS in compliance with Chapter 21 — including protocol review, HCP engagement structures, and the boundary with promotional activity.
Digital content accessible across multiple markets — ABPI Code jurisdiction questions, country of origin principles, and platform-specific compliance requirements.
Clear, structured compliance briefings for board-level and senior leadership audiences — translating Code obligations into commercially relevant business risk language.
What clients say
“We received a PMCPA complaint on a Friday afternoon. Anzal was on a call by Monday morning, had reviewed all materials by Tuesday, and we had a clear response strategy before the deadline. The case was resolved without a breach finding. Having someone who understood both the process and the strategy made all the difference.”— VP Regulatory Affairs, UK pharma company
“The pre-launch review flagged a structural issue with how we had classified our advisory board activity. If that had gone through, we would have been in breach of Chapter 18. That one engagement — one conversation before the materials were built — saved us considerably more than the cost of the advisory. It is the best return on a compliance investment I have seen.”— Country Medical Director, specialty pharma affiliate
Who this is for
Strategic advisory is most valuable when the situation is genuinely complex, genuinely novel, or genuinely high-stakes. If the decision matters and the consequences of getting it wrong are significant, this is built for you.
Immediate engagement from the point of complaint receipt — strategy, response drafting, and ongoing case management through to resolution.
Pre-inspection gap analysis, mock audit, and prioritised remediation plan — with written documentation of compliance decision-making to present to inspectors.
Patient engagement, NIS studies, named patient programmes, or digital campaigns structured in a way the company has not done before — advisory before the activity begins.
Board members and senior leadership who need to understand the compliance implications of planned commercial strategies in clear, commercially relevant terms.
Affiliates, emerging pharma companies, and smaller UK operations that need senior compliance expertise without the cost of a dedicated in-house hire.
Situations where internal expertise exists but the timeline, novelty, or stakes of the decision require an experienced external perspective before proceeding.
Common questions
Yes. Strategic advisory for PMCPA complaints covers the full process — from initial material review and response strategy through to drafting the formal written response, supporting any panel hearing process, and managing post-case undertakings. The level of involvement at each stage is discussed at the outset based on internal capacity and timeline.
Yes. Patient organisation interactions, non-interventional studies, disease awareness programmes, named patient schemes, and early access activities each have specific Code obligations distinct from standard HCP promotional activity. Strategic advice on how to structure these activities — to meet both the compliance requirements and the commercial objective — is a core part of this service.
The engagement begins with a process audit — review of current SOPs, governance documentation, materials approval records, and decision-making trails. A gap analysis is produced identifying areas of weakness relative to ABPI and MHRA audit expectations. A mock audit session follows, and a prioritised written report of recommendations is produced. The timeline is typically four to six weeks from engagement start to final report.
All three models are available and each has its place depending on your situation. Retained advisory suits organisations that need ongoing access to senior compliance expertise across multiple questions and projects. Project-based engagements are structured around a defined deliverable — a complaint, a launch, an audit. Ad hoc advisory provides access to expert guidance for specific questions without a formal engagement structure. The right model is discussed on the initial consultation call.
Book a consultation to discuss your specific situation — whether it is a complaint, a launch, an inspection, or a question you have not been able to answer internally.
Request a Consultation →Need instant answers?
ABPI Code compliance, pharmacovigilance, GVP modules, signal detection and more. Ask anything, get structured referenced answers in seconds. From £9/month.
Free Resource
A step-by-step guide to navigating a PMCPA investigation — the timeline, what to do in the first 48 hours, how to build your defence, common mistakes, and when to appeal.
Enter your details to get instant access:
One real case. One key lesson. Every week — free.